Longevity Quest: A New Race to Keep Us Younger

Jamie Justice once taught biology at Wake Forest University. She decided to leave that steady post and team up with entrepreneur Peter Diamandis on a bold venture called XPRIZE Healthspan. The goal? To find real treatments that can restore muscle, memory and immune power in older people. The competition is huge. It offers $101 million for teams that can prove their therapies work in long, well‑controlled clinical trials. In 2024, ten teams were chosen from about forty applicants. They must run a year‑long study to see if their ideas truly slow aging before the final prize is awarded in 2030. Justice explained this plan at a recent longevity gathering, Vitalist Bay. She pointed out that the market for anti‑aging products is growing fast, but nobody knows which ones actually help. XPRIZE Healthspan was designed to close that knowledge gap by demanding rigorous proof.The competitors are using a mix of strategies. Some focus on exercise programs, others develop senolytics—drugs that clear out damaged “zombie” cells that pile up with age. A few teams are working on personalized medicine, tailoring treatments to individual biomarkers that signal aging. The event highlighted how diverse the field has become. While some researchers push for lifestyle changes, others dive into cutting‑edge biology to tweak the body’s own repair systems. Each approach reflects a different belief about how best to keep us healthy longer. The race is not just about money. It’s also a test of how science, business and public health can collaborate to solve one of humanity’s biggest challenges. If any team succeeds, it could set a new standard for proving anti‑aging therapies and change the way we think about growing old.